Hypertension 2025 Scientific Sessions  /  Corcept Therapeutics Sponsored Learning Studio Cracking the Code: Uncover a Hidden Driver of Resistant Hypertension  /  Cracking the Code: Uncover a Hidden Driver of Resistant Hypertension
Logo

American Heart Association

  67
  0

Final ID:

Cracking the Code: Uncover a Hidden Driver of Resistant Hypertension

  • Basile, Jan  ( Medical University of S Carolina , Charleston , South Carolina , United States )
  • Pantalone, Kevin  ( Cleveland Clinic Lerner College of Medicine , Cleveland , Ohio , United States )
  • Townsend, Raymond  ( PENNSYLVANIA SCHOOL MED UNIV , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Jan Basile: DO have relevant financial relationships ; Consultant:up to date:Active (exists now) ; Consultant:Corcept:Active (exists now) ; Research Funding (PI or named investigator):Corcept:Active (exists now) ; Research Funding (PI or named investigator):Lilly:Active (exists now) ; Consultant:Blue Earth Diagnostics:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Mineralys:Active (exists now) ; Consultant:Idorsia:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) | Kevin Pantalone: No Answer | Raymond Townsend: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Consultant:Orchestra Backbeat:Active (exists now) ; Consultant:Bard:Active (exists now) ; Consultant:Regeneron:Active (exists now) ; Consultant:AstraZeneca:Active (exists now)
Meeting Info:

Hypertension 2025 Scientific Sessions

2025

Baltimore, Maryland

Session Info:

Corcept Therapeutics Sponsored Learning Studio Cracking the Code: Uncover a Hidden Driver of Resistant Hypertension

Saturday, 09/06/2025 , 12:30PM - 01:00PM

Learning Studio

More abstracts from these authors:
Renal Denervation- Review of AHA Scientific Statement

Cluett Jennifer, Townsend Raymond, Griffin Karen

BPROAD Research Group. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease. Nephrol Dial Transplant

Townsend Raymond

You have to be authorized to contact abstract author. Please, Login
Not Available